Sources and Dosing

Comparing fish oil, algae oil, and food sources, plus how much you actually need

You can get EPA and DHA from fatty fish like salmon, mackerel, and sardines, or from supplements like fish oil and algae oil. If you eat two servings of fatty fish per week, you're likely getting a good baseline. If not, a supplement can help fill the gap.

Fish oil is the most common supplement form, but algae-based omega-3s are a solid alternative, especially if you're vegetarian, vegan, or concerned about ocean sustainability. Both deliver EPA and DHA in forms your body can use.

Most health organizations suggest around 250-500 mg of combined EPA and DHA per day for general health [1].

Food sources vary widely in EPA and DHA content. A 3-ounce serving of Atlantic salmon provides roughly 1,200-2,400 mg of combined EPA and DHA, while the same amount of canned tuna provides about 200-500 mg. Sardines, mackerel, herring, and anchovies are also excellent sources [1].

Fish oil supplements typically come in three molecular forms: natural triglyceride, ethyl ester, and re-esterified triglyceride. Bioavailability differs meaningfully between these forms. The triglyceride forms (natural and re-esterified) show roughly 50-70% better absorption than ethyl esters, particularly when taken without a fatty meal [2]. A standard fish oil capsule (1,000 mg of oil) typically contains 300-500 mg of combined EPA and DHA, though concentrated formulations may contain 700-900 mg.

Algae oil is derived from microalgae, the original source of omega-3s in the marine food chain. Fish accumulate EPA and DHA by eating algae and smaller fish, so algae oil goes directly to the source. Most commercially available algae supplements are rich in DHA, though newer formulations also provide meaningful EPA [3][5]. Studies show algae-derived DHA is bioequivalent to DHA from fish oil [5].

Dosing guidance depends on your goals. For general health maintenance, 250-500 mg/day of combined EPA and DHA is the most commonly cited range [1]. For triglyceride reduction, clinical trials have used 2,000-4,000 mg/day of EPA and DHA, typically under medical supervision [4]. The FDA considers up to 3,000 mg/day from supplements to be generally recognized as safe [4].

Taking omega-3 supplements with a meal containing some fat improves absorption, regardless of the molecular form [2].

The choice of omega-3 source and formulation has meaningful implications for bioavailability, sustainability, and clinical outcomes.

Bioavailability of different formulations. Schuchardt and Hahn (2013) conducted a systematic review of 21 human studies comparing omega-3 bioavailability across formulations. They found that re-esterified triglycerides showed the highest bioavailability, followed by natural triglycerides and free fatty acids, with ethyl esters demonstrating the lowest absorption. The difference was particularly pronounced in fasting conditions: ethyl ester absorption was 73% lower than triglyceride absorption when taken without food. In fed conditions (with a high-fat meal), the gap narrowed but remained significant at approximately 30% [2]. This finding has practical implications for supplement selection and dosing instructions.

Algae-derived omega-3s. Lane et al. (2014) reviewed the evidence for microalgal omega-3 sources and found that algae oil DHA is bioequivalent to fish-derived DHA in randomized controlled trials, producing comparable increases in blood DHA levels [5]. Adarme-Vega et al. (2012) described the cultivation of DHA-producing microalgae species, primarily Schizochytrium and Crypthecodinium, noting that algal production avoids the heavy metal contamination and environmental concerns associated with fish-derived oils [3]. Algae cultivation also avoids bycatch and overfishing concerns, making it the more sustainable option from an ecological standpoint.

Regulatory and safety considerations. The FDA has issued qualified health claims for omega-3 fatty acids, acknowledging supportive but not conclusive evidence for cardiovascular benefit. The agency considers dietary supplements providing up to 3 g/day of EPA and DHA to be generally recognized as safe, while prescription omega-3 products delivering 4 g/day are approved specifically for severe hypertriglyceridemia (>500 mg/dL) [4]. Common side effects at higher doses include fishy aftertaste, gastrointestinal discomfort, and a theoretical increase in bleeding risk, though the latter has not been confirmed in clinical trials at doses up to 4 g/day.

Dosing evidence by indication. The NIH Office of Dietary Supplements summarizes dosing evidence as follows: general cardiovascular health, 250-500 mg/day combined EPA+DHA; secondary prevention of coronary heart disease, 1,000 mg/day; triglyceride lowering, 2,000-4,000 mg/day. There is no established Recommended Dietary Allowance (RDA) for EPA or DHA specifically, though the Adequate Intake for total omega-3s (including ALA) is 1.1-1.6 g/day for adults. The International Society for the Study of Fatty Acids and Lipids (ISSFAL) recommends a minimum of 500 mg/day combined EPA+DHA for cardiovascular health [1].

For individuals who do not consume fish, an algae-based supplement providing at least 250 mg DHA (and ideally EPA as well) is a well-supported alternative with equivalent bioavailability and no concerns about marine contaminants [3][5].

References

Omega-3 Fatty Acids - Fact Sheet for Health ProfessionalsNational Institutes of Health, Office of Dietary Supplements. NIH Office of Dietary Supplements, 2023. Source →
Bioavailability of marine n-3 fatty acid formulationsSchuchardt JP, Hahn A. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2013. PubMed 24261532 →
Docosahexaenoic acid production from microalgae and its benefits for use in animal feedsAdarme-Vega TC, Lim DK, Timmins M, Vernen F, Li Y, Schenk PM. Lipid Technology, 2012. PubMed 27472373 →
Qualified Health Claims: Letters of Enforcement Discretion - Omega-3 Fatty AcidsU.S. Food and Drug Administration. FDA, 2019. Source →
Long-chain omega-3 fatty acids: microalgal sources, bioavailability, and human health effectsLane K, Derbyshire E, Li W, Brennan C. Current Nutrition and Food Science, 2014. PubMed 24505395 →

Sources and Dosing

References

Transparency

Weekly Research Digest